Company Name
Drug
Event
Outcome
Details
Ardelyx, Inc
(ARDX)
Tenapanor (NDA)
07/29/2021
FDA decision on Tenapanor for control of serum phosphorus in adult patients with chronic kidney disease on dialysis
FDA issued a Complete Response Letter for Tenapanor on Jul.29, 2021-
Sol-Gel Technologies Ltd.
(SLGL)
Twyneo (NDA)
08/01/2021
FDA decision on Twyneo for the treatment of acne vulgaris
FDA approved Twyneo for the treatment of acne vulgaris on Jul.27, 2021-
Pfizer Inc.
(PFE)
TicoVac (BLA)
Aug 2021
FDA decision on TicoVac vaccine for tick-borne encephalitis
-
Read More Get Access to Premium FDA Calendar with RTT Biotech Investor.